Oryx 250 mg/vial (IM Injection)
250 mg vial: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Rangs pharmaceuticals ltd |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
- Broad-spectrum parenteral cephalosporin antibiotic
- Bactericidal activity against a wide range of Gram-positive and Gram-negative organisms
- Interferes with the synthesis of the bacterial cell wall
- High stability in the presence of beta lactamases
- Long plasma elimination half-life of about 6 to 9 hours
- Not metabolized in the body
- Highly protein bound (95%)
Dosage
- Adult: 1 to 2 gm by intravenous or intramuscular administration once a day
- Infants and Children (01 month or older): 50 to 75 mg/kg intravenous or intramuscular administration once a day
- Uncomplicated gonococcal infections: 250 mg IM as a single dose
- Surgical prophylaxis: 1 g IV as a single dose 30 to 120 minutes before surgery
- Duration of therapy: Usual duration is 4 to 14 days; longer therapy may be required in complicated infections
Administration
- Preparation of Solutions for Intramuscular / Intravenous Injections
- Intramuscular Injection preparation with Lidocaine HCI 1%
- Intravenous Injection preparation with Water for injection
- Injection administered over 2-4 minutes
Interaction
No drug interactions reported
Contraindications
Hypersensitivity to cephalosporin antibiotics
Side Effects
- Gastro-intestinal effects including diarrhea, nausea, vomiting, stomatitis, and glossitis
- Cutaneous reactions including rash, pruritus, urticaria, edema, and erythema multiforme
- Hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia, and neutropenia
- Hepatic reactions including elevations of SGOT or SGPT, bilirubinemia
- CNS reactions including nervousness, confusion, sleep disturbances, headache, hyperactivity, convulsion, hypertonia, and dizziness
- Local phlebitis following intravenous administration
Pregnancy & Lactation
Unsafe in human pregnancy, caution in lactation
Precautions & Warnings
- Risk of anaphylactic shock
- Possible gallbladder sludge detected
- Regular blood picture checks during prolonged treatment
Use in Special Populations
Avoid in premature and newborn neonates
Overdose Effects
No specific antidote, symptomatic treatment
Therapeutic Class
Third generation Cephalosporins
Storage Conditions
Store in a cool, dry place (below 30°C), away from light and moisture